ATE376840T1 - Gentherapeutika - Google Patents

Gentherapeutika

Info

Publication number
ATE376840T1
ATE376840T1 AT00908055T AT00908055T ATE376840T1 AT E376840 T1 ATE376840 T1 AT E376840T1 AT 00908055 T AT00908055 T AT 00908055T AT 00908055 T AT00908055 T AT 00908055T AT E376840 T1 ATE376840 T1 AT E376840T1
Authority
AT
Austria
Prior art keywords
gene
affinity
functional substance
efficacious amount
gene therapeutics
Prior art date
Application number
AT00908055T
Other languages
English (en)
Inventor
Ikunoshin Kato
Kiyozo Asada
Mitsuhiro Ueno
Kimikazu Hashino
Hirofumi Yoshioka
Keiji Tanaka
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Application granted granted Critical
Publication of ATE376840T1 publication Critical patent/ATE376840T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00908055T 1999-03-23 2000-03-14 Gentherapeutika ATE376840T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7859199 1999-03-23

Publications (1)

Publication Number Publication Date
ATE376840T1 true ATE376840T1 (de) 2007-11-15

Family

ID=13666162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00908055T ATE376840T1 (de) 1999-03-23 2000-03-14 Gentherapeutika

Country Status (9)

Country Link
US (1) US20060166924A1 (de)
EP (1) EP1163912B1 (de)
KR (1) KR100674140B1 (de)
CN (1) CN1225285C (de)
AT (1) ATE376840T1 (de)
AU (1) AU2944100A (de)
DE (1) DE60036929T2 (de)
TW (1) TWI272107B (de)
WO (1) WO2000056368A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100888915B1 (ko) 2001-08-15 2009-03-16 다카라 바이오 가부시키가이샤 항원특이적 세포상해성 ｔ 세포 확대배양방법
JP4406566B2 (ja) 2002-03-25 2010-01-27 タカラバイオ株式会社 細胞傷害性リンパ球の製造方法
KR101331746B1 (ko) 2003-08-22 2013-11-20 다카라 바이오 가부시키가이샤 세포 상해성 림프구의 제조 방법
EP1916302A4 (de) 2005-08-17 2009-10-21 Takara Bio Inc Verfahren zur herstellung von lymphozyten
JP5156382B2 (ja) * 2005-09-30 2013-03-06 タカラバイオ株式会社 Ｔ細胞集団の製造方法
AU2020282758A1 (en) * 2019-05-30 2021-12-23 Immunolux International Corp. Use of poxvirus with autologous induced pluripotent stem cells for vaccination and disease therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686278A (en) * 1994-03-25 1997-11-11 Indiana University Foundation Methods for enhanced retrovirus-mediated gene transfer
CA2158926A1 (en) * 1994-05-13 1995-11-14 Douglas J. Jolly Compositions and methods for targeting gene delivery vehicles
GB9506466D0 (en) * 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
FR2726005B1 (fr) * 1994-10-10 1997-01-03 Adim Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
KR100353115B1 (ko) * 1995-11-13 2003-01-06 다카라츠죠 가부시키가이샤 레트로바이러스를사용한표적세포내로의유전자도입방법
WO1997031656A1 (fr) * 1996-03-01 1997-09-04 Dnavec Research Inc. Composition pour introduire de maniere stable des genes dans des cellules hepatiques et procede pour introduire des genes a l'aide de cette composition
ES2277438T3 (es) * 1998-07-01 2007-07-01 Takara Bio Inc. Metodos de transferencia de genes.

Also Published As

Publication number Publication date
KR100674140B1 (ko) 2007-01-26
EP1163912A4 (de) 2003-08-06
KR20010102547A (ko) 2001-11-15
TWI272107B (en) 2007-02-01
AU2944100A (en) 2000-10-09
US20060166924A1 (en) 2006-07-27
WO2000056368A1 (en) 2000-09-28
DE60036929D1 (de) 2007-12-13
DE60036929T2 (de) 2008-08-07
EP1163912A1 (de) 2001-12-19
CN1345248A (zh) 2002-04-17
CN1225285C (zh) 2005-11-02
EP1163912B1 (de) 2007-10-31

Similar Documents

Publication Publication Date Title
BR0316234A (pt) Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos
ATE308999T1 (de) Intrazellulare expression von carboxypeptidase g2 in enzyme-prodrug-therapie
DE50211045D1 (de) Medizinische aerosolformulierungen
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
EP1411118A4 (de) Zellproliferationsinhibitoren mit anti-glypican-3-antikörper
TR199800046A2 (xx) Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu.
BR0014282A (pt) Vacinas
NL980011I2 (nl) 7-Piperazinyl- of 7-Morfolino-4-oxo-chinoline-3-carbonzuurderivaten, hun bereiding en hun gebruik als antimicrobiële middelen.
ATE231509T1 (de) 1,5-dihydro-pyrazolo 3,4-d)-pyrimidinon-derivate
PT751939E (pt) Naftilamidas como agentes para o sistema nervoso central
DE60016798D1 (de) Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
DE60036929D1 (de) Gentherapeutika
DE60132443D1 (de) In lebenden zielzellen
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
DE60142899D1 (de) Verbindungen für den transfer von oligonukleotiden
MEP18508A (en) Pharmaceutical composition and preparation thereof
DK52685D0 (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
TR200201148T2 (tr) Haşerat ilacı terkipleri ve metodları.
ATE353642T1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
BRPI0409683A (pt) 5-hidroxiindóis com grupos n-óxido e seu emprego como agentes terapêuticos
WO2000063348A3 (fr) Composition pharmaceutique comprenant des cellules nkt activees par des pim, et son utilisation en therapie
DK592885D0 (da) 2-azolylmethyl-3-difluorbenzyloxy-2,3-dihydrofluor-benzo(b)thiophener, fremgangsmaade til deres fremstilling og kompositioner indeholdendeforbindelserne
FI20030379A0 (fi) Uusi farmaseuttinen koostumus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties